Home › Companies › NEOGENOMICS INC. › 2023-2024
Compiled from SEC Form N-PX filings and NEOGENOMICS INC.’s Form 8-K, filed May 24, 2024 (Item 5.07 on EDGAR). Page generated October 25, 2026.
Meeting of May 23, 2024: 12 items on NEOGENOMICS INC.’s Form 8-K, filed May 24, 2024: 9 elected · 2 approved · 1 without a stated outcome.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore NEOGENOMICS INC. in the interactive database Compare manager voting policies
These tallies are NEOGENOMICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 24, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Lynn A. Tetrault | 83,003,873 | -- | -- | 27,070,660 | 7,524,229 | 75% | Elected | — |
| Elect Director: Christopher M. Smith | 109,124,682 | -- | -- | 949,851 | 7,524,229 | 99.1% | Elected | — |
| Elect Director: Dr. Alison L. Hannah | 107,190,288 | -- | -- | 2,884,245 | 7,524,229 | 97% | Elected | — |
| Elect Director: Stephen M. Kanovsky | 107,073,992 | -- | -- | 3,000,541 | 7,524,229 | 97% | Elected | — |
| Elect Director: Michael A. Kelly | 84,662,179 | -- | -- | 25,412,354 | 7,524,229 | 77% | Elected | — |
| Elect Director: David B. Perez | 109,230,796 | -- | -- | 843,737 | 7,524,229 | 99.2% | Elected | — |
| Elect Director: Anthony P. Zook | 108,543,639 | -- | -- | 1,530,894 | 7,524,229 | 99% | Elected | — |
| Elect Director: Elizabeth Floegel | 109,748,045 | -- | -- | 326,488 | 7,524,229 | 99.7% | Elected | — |
| Elect Director: Dr. Neil Gunn | 108,284,625 | -- | -- | 1,789,908 | 7,524,229 | 98% | Elected | — |
| 2. The approval, on an advisory basis, of the compensation paid to the Company's Named Executive Officers, as identified in the proxy statement for the annual meeting. The advisory approval received an affirmative vote of a majority of the votes cast by stockh | 76,045,753 | 33,308,929 | 719,851 | -- | -- | 70% | Not verified | a majority of the votes cast |
| 3. The approval of the Fourth Amendment of the Employee Stock Purchase Plan, as amended and restated, as identified in the proxy statement for the annual meeting | 109,699,121 | 246,194 | 129,218 | -- | -- | 99.7% | Approved | — |
| 4. The ratification of the appointment of Deloitte & Touche LLP as the independent registered public accountant | 117,159,931 | 384,034 | 54,797 | -- | -- | 99.6% | Approved | — |
Source: NEOGENOMICS INC., Form 8-K, filed with the SEC on May 24, 2024 — read the filing on EDGAR.
Each item below shows how the 313 asset managers that disclosed a NEOGENOMICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 4 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Description as filed by funds: Election of the directors named in the proxy statement as set forth below: Anthony P. Zook
NEOGENOMICS INC.’s own tally for this item (“Elect Director: Anthony P. Zook”): 108,543,639 for, 1,530,894 withheld, per its Form 8-K filed May 24, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The stockholders elected the nine directors by the following votes: (2)”
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 91 asset managers below reported 65,355,893 for, 624,820 withheld, 21,809 abstained, 98,642 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,967,210 | 0 | 0 | 0 | For |
| BlackRock | 12,124,771 | 0 | 0 | 0 | For |
| T. Rowe Price | 5,198,184 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 4,620,801 | 0 | 0 | 0 | For |
| Brown Advisory Funds | 3,130,987 | 0 | 0 | 0 | For |
| Fidelity | 2,778,135 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 2,495,020 | 0 | 0 | 0 | For |
| American Century | 2,181,042 | 0 | 0 | 0 | For |
| State Street | 1,893,691 | 0 | 0 | 0 | For |
| Principal | 1,705,777 | 0 | 0 | 0 | For |
| Goldman Sachs | 1,348,970 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 1,270,400 | 0 | 0 | 0 | For |
| GLENMEDE FUND INC | 1,057,049 | 0 | 0 | 0 | For |
| Charles Schwab | 1,011,557 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 817,438 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 732,200 | 0 | 0 | 0 | For |
| Waddell & Reed | 710,769 | 0 | 0 | 0 | For |
| Putnam | 667,082 | 0 | 0 | 0 | For |
| ALGER FUNDS | 643,942 | 0 | 0 | 0 | For |
| Prudential/PGIM | 550,650 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 516,669 | 0 | 0 | 0 | For |
| TIAA | 0 | 0 | 0 | 512,421 | Withhold |
| Royce | 398,077 | 0 | 0 | 0 | For |
| Segall Bryant & Hamill Trust | 379,358 | 0 | 0 | 0 | For |
| Equitable | 356,726 | 0 | 0 | 0 | For |
Showing the 25 largest of 91 asset managers. See all 91 in the interactive database.
Combines 4 wordings of this item as funds reported it.
99.1% Majority: yes · of votes cast
Description as filed by funds: Election of the directors named in the proxy statement as set forth below: Christopher M. Smith
NEOGENOMICS INC.’s own tally for this item (“Elect Director: Christopher M. Smith”): 109,124,682 for, 949,851 withheld, per its Form 8-K filed May 24, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The stockholders elected the nine directors by the following votes: (2)”
Support: 99.1% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 91 asset managers below reported 65,991,927 for, 10,595 withheld, 98,642 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,967,210 | 0 | 0 | 0 | For |
| BlackRock | 12,124,771 | 0 | 0 | 0 | For |
| T. Rowe Price | 5,198,184 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 4,620,801 | 0 | 0 | 0 | For |
| Brown Advisory Funds | 3,130,987 | 0 | 0 | 0 | For |
| Fidelity | 2,778,135 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 2,495,020 | 0 | 0 | 0 | For |
| American Century | 2,181,042 | 0 | 0 | 0 | For |
| State Street | 1,893,253 | 0 | 0 | 438 | For |
| Principal | 1,705,777 | 0 | 0 | 0 | For |
| Goldman Sachs | 1,348,970 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 1,270,400 | 0 | 0 | 0 | For |
| GLENMEDE FUND INC | 1,057,049 | 0 | 0 | 0 | For |
| Charles Schwab | 1,011,557 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 817,438 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 732,200 | 0 | 0 | 0 | For |
| Waddell & Reed | 710,769 | 0 | 0 | 0 | For |
| Putnam | 667,082 | 0 | 0 | 0 | For |
| ALGER FUNDS | 643,942 | 0 | 0 | 0 | For |
| Prudential/PGIM | 550,650 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 516,669 | 0 | 0 | 0 | For |
| TIAA | 512,421 | 0 | 0 | 0 | For |
| Royce | 398,077 | 0 | 0 | 0 | For |
| Segall Bryant & Hamill Trust | 379,358 | 0 | 0 | 0 | For |
| Equitable | 356,726 | 0 | 0 | 0 | For |
Showing the 25 largest of 91 asset managers. See all 91 in the interactive database.
Combines 3 wordings of this item as funds reported it.
99.2% Majority: yes · of votes cast
Description as filed by funds: Election of the directors named in the proxy statement as set forth below: David B. Perez
NEOGENOMICS INC.’s own tally for this item (“Elect Director: David B. Perez”): 109,230,796 for, 843,737 withheld, per its Form 8-K filed May 24, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The stockholders elected the nine directors by the following votes: (2)”
Support: 99.2% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 91 asset managers below reported 65,991,927 for, 10,595 withheld, 98,642 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,967,210 | 0 | 0 | 0 | For |
| BlackRock | 12,124,771 | 0 | 0 | 0 | For |
| T. Rowe Price | 5,198,184 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 4,620,801 | 0 | 0 | 0 | For |
| Brown Advisory Funds | 3,130,987 | 0 | 0 | 0 | For |
| Fidelity | 2,778,135 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 2,495,020 | 0 | 0 | 0 | For |
| American Century | 2,181,042 | 0 | 0 | 0 | For |
| State Street | 1,893,253 | 0 | 0 | 438 | For |
| Principal | 1,705,777 | 0 | 0 | 0 | For |
| Goldman Sachs | 1,348,970 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 1,270,400 | 0 | 0 | 0 | For |
| GLENMEDE FUND INC | 1,057,049 | 0 | 0 | 0 | For |
| Charles Schwab | 1,011,557 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 817,438 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 732,200 | 0 | 0 | 0 | For |
| Waddell & Reed | 710,769 | 0 | 0 | 0 | For |
| Putnam | 667,082 | 0 | 0 | 0 | For |
| ALGER FUNDS | 643,942 | 0 | 0 | 0 | For |
| Prudential/PGIM | 550,650 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 516,669 | 0 | 0 | 0 | For |
| TIAA | 512,421 | 0 | 0 | 0 | For |
| Royce | 398,077 | 0 | 0 | 0 | For |
| Segall Bryant & Hamill Trust | 379,358 | 0 | 0 | 0 | For |
| Equitable | 356,726 | 0 | 0 | 0 | For |
Showing the 25 largest of 91 asset managers. See all 91 in the interactive database.
Combines 5 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: Election of the directors named in the proxy statement as set forth below: Dr. Alison L. Hannah
NEOGENOMICS INC.’s own tally for this item (“Elect Director: Dr. Alison L. Hannah”): 107,190,288 for, 2,884,245 withheld, per its Form 8-K filed May 24, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The stockholders elected the nine directors by the following votes: (2)”
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 91 asset managers below reported 65,252,862 for, 749,660 withheld, 98,642 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,967,210 | 0 | 0 | 0 | For |
| BlackRock | 12,124,771 | 0 | 0 | 0 | For |
| T. Rowe Price | 5,198,184 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 4,620,801 | 0 | 0 | 0 | For |
| Brown Advisory Funds | 3,130,987 | 0 | 0 | 0 | For |
| Fidelity | 2,778,135 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 2,495,020 | 0 | 0 | 0 | For |
| American Century | 2,181,042 | 0 | 0 | 0 | For |
| State Street | 1,892,916 | 0 | 0 | 775 | For |
| Principal | 1,705,777 | 0 | 0 | 0 | For |
| Goldman Sachs | 1,348,970 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 1,270,400 | 0 | 0 | 0 | For |
| GLENMEDE FUND INC | 1,057,049 | 0 | 0 | 0 | For |
| Charles Schwab | 1,011,557 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 817,438 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 732,200 | 0 | 0 | 0 | For |
| Waddell & Reed | 710,769 | 0 | 0 | 0 | For |
| Putnam | 667,082 | 0 | 0 | 0 | For |
| ALGER FUNDS | 0 | 0 | 0 | 643,942 | Withhold |
| Prudential/PGIM | 550,650 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 516,669 | 0 | 0 | 0 | For |
| TIAA | 512,421 | 0 | 0 | 0 | For |
| Royce | 398,077 | 0 | 0 | 0 | For |
| Segall Bryant & Hamill Trust | 379,358 | 0 | 0 | 0 | For |
| Equitable | 356,726 | 0 | 0 | 0 | For |
Showing the 25 largest of 91 asset managers. See all 91 in the interactive database.
Combines 4 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Election of the directors named in the proxy statement as set forth below: Dr. Neil Gunn
NEOGENOMICS INC.’s own tally for this item (“Elect Director: Dr. Neil Gunn”): 108,284,625 for, 1,789,908 withheld, per its Form 8-K filed May 24, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The stockholders elected the nine directors by the following votes: (2)”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 91 asset managers below reported 65,377,702 for, 624,820 withheld, 98,642 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,967,210 | 0 | 0 | 0 | For |
| BlackRock | 12,124,771 | 0 | 0 | 0 | For |
| T. Rowe Price | 5,198,184 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 4,620,801 | 0 | 0 | 0 | For |
| Brown Advisory Funds | 3,130,987 | 0 | 0 | 0 | For |
| Fidelity | 2,778,135 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 2,495,020 | 0 | 0 | 0 | For |
| American Century | 2,181,042 | 0 | 0 | 0 | For |
| State Street | 1,893,691 | 0 | 0 | 0 | For |
| Principal | 1,705,777 | 0 | 0 | 0 | For |
| Goldman Sachs | 1,348,970 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 1,270,400 | 0 | 0 | 0 | For |
| GLENMEDE FUND INC | 1,057,049 | 0 | 0 | 0 | For |
| Charles Schwab | 1,011,557 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 817,438 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 732,200 | 0 | 0 | 0 | For |
| Waddell & Reed | 710,769 | 0 | 0 | 0 | For |
| Putnam | 667,082 | 0 | 0 | 0 | For |
| ALGER FUNDS | 643,942 | 0 | 0 | 0 | For |
| Prudential/PGIM | 550,650 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 516,669 | 0 | 0 | 0 | For |
| TIAA | 0 | 0 | 0 | 512,421 | Withhold |
| Royce | 398,077 | 0 | 0 | 0 | For |
| Segall Bryant & Hamill Trust | 379,358 | 0 | 0 | 0 | For |
| Equitable | 356,726 | 0 | 0 | 0 | For |
Showing the 25 largest of 91 asset managers. See all 91 in the interactive database.
Combines 3 wordings of this item as funds reported it.
99.7% Majority: yes · of votes cast
Description as filed by funds: Election of the directors named in the proxy statement as set forth below: Elizabeth Floegel
NEOGENOMICS INC.’s own tally for this item (“Elect Director: Elizabeth Floegel”): 109,748,045 for, 326,488 withheld, per its Form 8-K filed May 24, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The stockholders elected the nine directors by the following votes: (2)”
Support: 99.7% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 91 asset managers below reported 65,992,365 for, 10,157 withheld, 98,642 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,967,210 | 0 | 0 | 0 | For |
| BlackRock | 12,124,771 | 0 | 0 | 0 | For |
| T. Rowe Price | 5,198,184 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 4,620,801 | 0 | 0 | 0 | For |
| Brown Advisory Funds | 3,130,987 | 0 | 0 | 0 | For |
| Fidelity | 2,778,135 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 2,495,020 | 0 | 0 | 0 | For |
| American Century | 2,181,042 | 0 | 0 | 0 | For |
| State Street | 1,893,691 | 0 | 0 | 0 | For |
| Principal | 1,705,777 | 0 | 0 | 0 | For |
| Goldman Sachs | 1,348,970 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 1,270,400 | 0 | 0 | 0 | For |
| GLENMEDE FUND INC | 1,057,049 | 0 | 0 | 0 | For |
| Charles Schwab | 1,011,557 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 817,438 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 732,200 | 0 | 0 | 0 | For |
| Waddell & Reed | 710,769 | 0 | 0 | 0 | For |
| Putnam | 667,082 | 0 | 0 | 0 | For |
| ALGER FUNDS | 643,942 | 0 | 0 | 0 | For |
| Prudential/PGIM | 550,650 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 516,669 | 0 | 0 | 0 | For |
| TIAA | 512,421 | 0 | 0 | 0 | For |
| Royce | 398,077 | 0 | 0 | 0 | For |
| Segall Bryant & Hamill Trust | 379,358 | 0 | 0 | 0 | For |
| Equitable | 356,726 | 0 | 0 | 0 | For |
Showing the 25 largest of 91 asset managers. See all 91 in the interactive database.
Combines 3 wordings of this item as funds reported it.
75% Majority: yes · of votes cast
Description as filed by funds: Election of the directors named in the proxy statement as set forth below: Lynn A. Tetrault
NEOGENOMICS INC.’s own tally for this item (“Elect Director: Lynn A. Tetrault”): 83,003,873 for, 27,070,660 withheld, per its Form 8-K filed May 24, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The stockholders elected the nine directors by the following votes: (2)”
Support: 75% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 91 asset managers below reported 53,329,063 for, 12,673,459 withheld, 98,642 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,967,210 | 0 | 0 | 0 | For |
| BlackRock | 12,124,771 | 0 | 0 | 0 | For |
| T. Rowe Price | 4,733,386 | 0 | 0 | 464,798 | Mixed |
| JANUS INVESTMENT FUND | 3,693,982 | 0 | 0 | 926,819 | Mixed |
| Brown Advisory Funds | 3,130,987 | 0 | 0 | 0 | For |
| Fidelity | 2,778,135 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 0 | 0 | 0 | 2,495,020 | Withhold |
| American Century | 0 | 0 | 0 | 2,181,042 | Withhold |
| State Street | 1,890,624 | 0 | 0 | 3,067 | For |
| Principal | 1,560,229 | 0 | 0 | 145,548 | Mixed |
| Goldman Sachs | 1,348,970 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 1,270,400 | 0 | 0 | 0 | For |
| GLENMEDE FUND INC | 0 | 0 | 0 | 1,057,049 | Withhold |
| Charles Schwab | 1,011,557 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 817,438 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 0 | 0 | 0 | 732,200 | Withhold |
| Waddell & Reed | 0 | 0 | 0 | 710,769 | Withhold |
| Putnam | 667,082 | 0 | 0 | 0 | For |
| ALGER FUNDS | 0 | 0 | 0 | 643,942 | Withhold |
| Prudential/PGIM | 493,347 | 0 | 0 | 57,303 | Mixed |
| Columbia Threadneedle | 516,669 | 0 | 0 | 0 | For |
| TIAA | 0 | 0 | 0 | 512,421 | Withhold |
| Royce | 398,077 | 0 | 0 | 0 | For |
| Segall Bryant & Hamill Trust | 0 | 0 | 0 | 379,358 | Withhold |
| Equitable | 199,886 | 0 | 0 | 156,840 | Mixed |
Showing the 25 largest of 91 asset managers. See all 91 in the interactive database.
Combines 3 wordings of this item as funds reported it.
77% Majority: yes · of votes cast
Description as filed by funds: Election of the directors named in the proxy statement as set forth below: Michael A. Kelly
NEOGENOMICS INC.’s own tally for this item (“Elect Director: Michael A. Kelly”): 84,662,179 for, 25,412,354 withheld, per its Form 8-K filed May 24, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The stockholders elected the nine directors by the following votes: (2)”
Support: 77% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 91 asset managers below reported 53,329,063 for, 12,673,459 withheld, 98,642 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,967,210 | 0 | 0 | 0 | For |
| BlackRock | 12,124,771 | 0 | 0 | 0 | For |
| T. Rowe Price | 4,733,386 | 0 | 0 | 464,798 | Mixed |
| JANUS INVESTMENT FUND | 3,693,982 | 0 | 0 | 926,819 | Mixed |
| Brown Advisory Funds | 3,130,987 | 0 | 0 | 0 | For |
| Fidelity | 2,778,135 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 0 | 0 | 0 | 2,495,020 | Withhold |
| American Century | 0 | 0 | 0 | 2,181,042 | Withhold |
| State Street | 1,890,624 | 0 | 0 | 3,067 | For |
| Principal | 1,560,229 | 0 | 0 | 145,548 | Mixed |
| Goldman Sachs | 1,348,970 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 1,270,400 | 0 | 0 | 0 | For |
| GLENMEDE FUND INC | 0 | 0 | 0 | 1,057,049 | Withhold |
| Charles Schwab | 1,011,557 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 817,438 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 0 | 0 | 0 | 732,200 | Withhold |
| Waddell & Reed | 0 | 0 | 0 | 710,769 | Withhold |
| Putnam | 667,082 | 0 | 0 | 0 | For |
| ALGER FUNDS | 0 | 0 | 0 | 643,942 | Withhold |
| Prudential/PGIM | 493,347 | 0 | 0 | 57,303 | Mixed |
| Columbia Threadneedle | 516,669 | 0 | 0 | 0 | For |
| TIAA | 0 | 0 | 0 | 512,421 | Withhold |
| Royce | 398,077 | 0 | 0 | 0 | For |
| Segall Bryant & Hamill Trust | 0 | 0 | 0 | 379,358 | Withhold |
| Equitable | 199,886 | 0 | 0 | 156,840 | Mixed |
Showing the 25 largest of 91 asset managers. See all 91 in the interactive database.
Combines 4 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: Election of the directors named in the proxy statement as set forth below: Stephen M. Kanovsky
NEOGENOMICS INC.’s own tally for this item (“Elect Director: Stephen M. Kanovsky”): 107,073,992 for, 3,000,541 withheld, per its Form 8-K filed May 24, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The stockholders elected the nine directors by the following votes: (2)”
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 91 asset managers below reported 65,217,862 for, 762,851 withheld, 21,809 abstained, 98,642 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,967,210 | 0 | 0 | 0 | For |
| BlackRock | 12,124,771 | 0 | 0 | 0 | For |
| T. Rowe Price | 5,198,184 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 4,620,801 | 0 | 0 | 0 | For |
| Brown Advisory Funds | 3,130,987 | 0 | 0 | 0 | For |
| Fidelity | 2,778,135 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 2,495,020 | 0 | 0 | 0 | For |
| American Century | 2,181,042 | 0 | 0 | 0 | For |
| State Street | 1,892,916 | 0 | 0 | 775 | For |
| Principal | 1,705,777 | 0 | 0 | 0 | For |
| Goldman Sachs | 1,348,970 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 1,270,400 | 0 | 0 | 0 | For |
| GLENMEDE FUND INC | 1,057,049 | 0 | 0 | 0 | For |
| Charles Schwab | 1,011,557 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 817,438 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 732,200 | 0 | 0 | 0 | For |
| Waddell & Reed | 710,769 | 0 | 0 | 0 | For |
| Putnam | 667,082 | 0 | 0 | 0 | For |
| ALGER FUNDS | 0 | 0 | 0 | 643,942 | Withhold |
| Prudential/PGIM | 550,650 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 516,669 | 0 | 0 | 0 | For |
| TIAA | 512,421 | 0 | 0 | 0 | For |
| Royce | 398,077 | 0 | 0 | 0 | For |
| Segall Bryant & Hamill Trust | 379,358 | 0 | 0 | 0 | For |
| Equitable | 356,726 | 0 | 0 | 0 | For |
Showing the 25 largest of 91 asset managers. See all 91 in the interactive database.
Combines 4 wordings of this item as funds reported it.
99.7% Approved · of votes cast
Description as filed by funds: Approval of the Fourth Amendment of the NeoGenomics, Inc. Employee Stock Purchase Plan (as amended and restated).
NEOGENOMICS INC.’s own tally for this item (“3. The approval of the Fourth Amendment of the Employee Stock Purchase Plan, as amended and restated, as identified in the proxy statement for the annual meeting”): 109,699,121 for, 246,194 against — passed, per its Form 8-K filed May 24, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The stockholders approved the proposal by the following vote:”
Support: 99.7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,967,210 | 0 | 0 | 0 | For |
| BlackRock | 12,124,771 | 0 | 0 | 0 | For |
| T. Rowe Price | 5,198,184 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 4,620,801 | 0 | 0 | 0 | For |
| Brown Advisory Funds | 3,130,987 | 0 | 0 | 0 | For |
| Fidelity | 2,778,135 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 2,495,020 | 0 | 0 | 0 | For |
| American Century | 2,181,042 | 0 | 0 | 0 | For |
| State Street | 1,893,691 | 0 | 0 | 0 | For |
| Principal | 1,705,777 | 0 | 0 | 0 | For |
| Goldman Sachs | 1,348,970 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 1,270,400 | 0 | 0 | 0 | For |
| GLENMEDE FUND INC | 1,057,049 | 0 | 0 | 0 | For |
| Charles Schwab | 1,011,557 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 817,438 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 732,200 | 0 | 0 | 0 | For |
| Waddell & Reed | 710,769 | 0 | 0 | 0 | For |
| Putnam | 667,082 | 0 | 0 | 0 | For |
| ALGER FUNDS | 643,942 | 0 | 0 | 0 | For |
| Prudential/PGIM | 550,650 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 516,669 | 0 | 0 | 0 | For |
| TIAA | 512,421 | 0 | 0 | 0 | For |
| Royce | 398,077 | 0 | 0 | 0 | For |
| Segall Bryant & Hamill Trust | 379,358 | 0 | 0 | 0 | For |
| Equitable | 356,726 | 0 | 0 | 0 | For |
Fund voting reports, all 89 managers: 65,962,557 for, 10,157 against, 98,642 not voted. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| First Light Asset Management, LLC | 3,241,474 | 0 | 0 | 0 | For |
| HOWLAND CAPITAL MANAGEMENT LLC | 29,454 | 0 | 0 | 0 | For |
| Uniplan Investment Counsel, Inc. | 891 | 0 | 0 | 0 | For |
| Boltwood Capital Management | 354 | 0 | 0 | 0 | For |
Institutional-manager reports, all 4 managers: 3,272,173 for.
Combines 11 wordings of this item as funds reported it.
70% Majority: yes · of votes cast
Description as filed by funds: Approval, on an advisory basis, of the Compensation Paid to the Company's Named Executive Officers.
NEOGENOMICS INC.’s own tally for this item (“2. The approval, on an advisory basis, of the compensation paid to the Company's Named Executive Officers, as identified in the proxy statement for the annual meeting. The advisory approval received an affirmative vote o”): 76,045,753 for, 33,308,929 against, per its Form 8-K filed May 24, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 70% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Voting standard, as the filing states it: a majority of the votes cast (“majority of the votes cast”).
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,967,210 | 0 | 0 | 0 | For |
| BlackRock | 12,124,771 | 0 | 0 | 0 | For |
| T. Rowe Price | 4,733,386 | 464,798 | 0 | 0 | Mixed |
| JANUS INVESTMENT FUND | 3,693,982 | 926,819 | 0 | 0 | Mixed |
| Brown Advisory Funds | 3,130,987 | 0 | 0 | 0 | For |
| Fidelity | 2,778,135 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 0 | 2,495,020 | 0 | 0 | Against |
| American Century | 0 | 2,181,042 | 0 | 0 | Against |
| State Street | 1,890,624 | 3,067 | 0 | 0 | For |
| Principal | 1,560,229 | 145,548 | 0 | 0 | Mixed |
| Goldman Sachs | 550,854 | 798,116 | 0 | 0 | Mixed |
| FRANKLIN STRATEGIC SERIES | 1,270,400 | 0 | 0 | 0 | For |
| GLENMEDE FUND INC | 0 | 1,057,049 | 0 | 0 | Against |
| Charles Schwab | 1,011,557 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 817,438 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 0 | 732,200 | 0 | 0 | Against |
| Waddell & Reed | 0 | 710,769 | 0 | 0 | Against |
| Putnam | 667,082 | 0 | 0 | 0 | For |
| ALGER FUNDS | 0 | 643,942 | 0 | 0 | Against |
| Prudential/PGIM | 274,735 | 275,915 | 0 | 0 | Mixed |
| Columbia Threadneedle | 0 | 516,669 | 0 | 0 | Against |
| TIAA | 0 | 512,421 | 0 | 0 | Against |
| Royce | 0 | 0 | 398,077 | 0 | Abstain |
| Segall Bryant & Hamill Trust | 0 | 379,358 | 0 | 0 | Against |
| Equitable | 199,886 | 156,840 | 0 | 0 | Mixed |
Fund voting reports, all 89 managers: 50,384,412 for, 15,180,068 against, 408,234 abstained, 98,642 not voted. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| New York Life | 0 | 17,000,000 | 0 | 0 | Against |
| BROWN ADVISORY INC | 8,175,681 | 23,686 | 0 | 0 | For |
| T. Rowe Price | 6,804,592 | 624,256 | 0 | 0 | Mixed |
| Janus Henderson | 3,907,615 | 1,760,670 | 0 | 0 | Mixed |
| State Street | 4,374,820 | 44,711 | 0 | 0 | For |
| MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST | 0 | 3,765,090 | 0 | 0 | Against |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 0 | 3,485,106 | 0 | 0 | Against |
| BlackRock | 3,274,212 | 45,658 | 0 | 0 | For |
| First Light Asset Management, LLC | 3,241,474 | 0 | 0 | 0 | For |
| Greenhouse Funds LLLP | 3,038,278 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 2,863,333 | 0 | 0 | 0 | For |
| American Century | 0 | 2,415,797 | 0 | 0 | Against |
| WEATHERBIE CAPITAL, LLC | 0 | 1,572,727 | 0 | 0 | Against |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,557,895 | 0 | 0 | 0 | For |
| FRANKLIN ADVISERS INC | 1,285,450 | 57,264 | 0 | 0 | For |
| Northern Trust | 1,259,480 | 18,059 | 0 | 0 | For |
| Charles Schwab | 1,194,159 | 0 | 0 | 0 | For |
| Goldman Sachs | 913 | 1,172,007 | 0 | 0 | Against |
| Point72 | 0 | 934,679 | 0 | 0 | Against |
| EMERALD ADVISERS, LLC | 859,174 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 0 | 808,004 | 0 | 0 | Against |
| OBERWEIS ASSET MANAGEMENT INC/ | 0 | 732,200 | 0 | 0 | Against |
| Putnam | 700,902 | 0 | 0 | 0 | For |
| JENNISON ASSOCIATES LLC | 684,634 | 0 | 0 | 0 | For |
| PRINCIPAL GLOBAL INVESTORS | 0 | 661,863 | 0 | 0 | Against |
Institutional-manager reports, all 257 managers: 45,300,972 for, 43,569,879 against, 500 withheld, 213,642 abstained. Showing the 25 largest; see all in the interactive database.
Combines 4 wordings of this item as funds reported it.
99.6% Approved · of votes cast
Description as filed by funds: Ratification of the Appointment of Deloitte & Touche LLP as the Company's Independent Registered Public Accounting Firm.
NEOGENOMICS INC.’s own tally for this item (“4. The ratification of the appointment of Deloitte & Touche LLP as the independent registered public accountant”): 117,159,931 for, 384,034 against — passed, per its Form 8-K filed May 24, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The stockholders approved the proposal by the following vote:”
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 91 asset managers below reported 65,931,799 for, 60,566 against, 10,157 abstained, 98,642 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,967,210 | 0 | 0 | 0 | For |
| BlackRock | 12,124,771 | 0 | 0 | 0 | For |
| T. Rowe Price | 5,198,184 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 4,620,801 | 0 | 0 | 0 | For |
| Brown Advisory Funds | 3,130,987 | 0 | 0 | 0 | For |
| Fidelity | 2,778,135 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 2,495,020 | 0 | 0 | 0 | For |
| American Century | 2,181,042 | 0 | 0 | 0 | For |
| State Street | 1,893,691 | 0 | 0 | 0 | For |
| Principal | 1,705,777 | 0 | 0 | 0 | For |
| Goldman Sachs | 1,348,970 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 1,270,400 | 0 | 0 | 0 | For |
| GLENMEDE FUND INC | 1,057,049 | 0 | 0 | 0 | For |
| Charles Schwab | 1,011,557 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 817,438 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 732,200 | 0 | 0 | 0 | For |
| Waddell & Reed | 710,769 | 0 | 0 | 0 | For |
| Putnam | 667,082 | 0 | 0 | 0 | For |
| ALGER FUNDS | 643,942 | 0 | 0 | 0 | For |
| Prudential/PGIM | 550,650 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 516,669 | 0 | 0 | 0 | For |
| TIAA | 512,421 | 0 | 0 | 0 | For |
| Royce | 398,077 | 0 | 0 | 0 | For |
| Segall Bryant & Hamill Trust | 379,358 | 0 | 0 | 0 | For |
| Equitable | 356,726 | 0 | 0 | 0 | For |
Showing the 25 largest of 91 asset managers. See all 91 in the interactive database.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 127,434,786 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 10.96% |
| 2 | BlackRock | 9.51% |
| 3 | T. Rowe Price | 4.08% |
| 4 | JANUS INVESTMENT FUND | 3.63% |
| 5 | Brown Advisory Funds | 2.46% |
| 6 | Fidelity | 2.18% |
| 7 | Delaware/Macquarie | 1.96% |
| 8 | American Century | 1.71% |
| 9 | State Street | 1.49% |
| 10 | Principal | 1.34% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | New York Life | 13.34% |
| 2 | BROWN ADVISORY INC | 6.43% |
| 3 | T. Rowe Price | 5.83% |
| 4 | Janus Henderson | 4.45% |
| 5 | State Street | 3.47% |
| 6 | MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST | 2.95% |
| 7 | SCHRODER INVESTMENT MANAGEMENT GROUP | 2.73% |
| 8 | BlackRock | 2.61% |
| 9 | First Light Asset Management, LLC | 2.54% |
| 10 | Greenhouse Funds LLLP | 2.38% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| BlackRock | 15.14% | 13F |
| Vanguard Group | 10.91% | 13F |
| Brown Advisory Incorporated | 7.48% | DEF14A |
| T. Rowe Price Investment Management Inc. | 5.01% | DEF14A |
| State Street | 3.84% | 13F |
| Dimensional Fund Advisors | 2.44% | 13F |
| Geode Capital | 2.28% | 13F |
| Morgan Stanley | 2.09% | 13F |
| Point72 | 1.72% | 13F |
| Franklin Templeton | 1.67% | 13F |
Percentages above are of 127,434,786 shares outstanding, as reported by NEOGENOMICS INC. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from NEOGENOMICS INC.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on October 25, 2026; a live search always shows the current data.
At NEOGENOMICS INC.'s shareholder meeting held May 23, 2024, in the 2023-2024 proxy season, 313 asset managers reported how they voted on 12 ballot items in their SEC Form N-PX filings, covering 3,790 separate fund positions. On the most widely held item on that ballot — Approval, on an advisory basis, of the Compensation Paid to the Company's Named Executive… — FOR was 70% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: NEOGENOMICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 24, 2024.
NEOGENOMICS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.
Download data (CSV): ballot items · votes by manager · column guide.